
Lupin Limited has informed the Exchange regarding a press release dated July 24, 2025, titled "Lupin Receives US FDA Approvals for Liraglutide and Glucagon Injectable Products".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated July 24, 2025, titled "Lupin Receives US FDA Approvals for Liraglutide and Glucagon Injectable Products".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin